Showing results (5211-5220 of 9,818) with videos related to
Sort By:
Pageof 982
Peptides|January 1, 1996
The in vivo metabolism of cholecystokinin (CCK-8) is essentially ensured by aminopeptidase AM Migaud, C Durieux, J Viereck, et al.Peptides|January 1, 1996
Enterostatin in gut endocrine cells--immunocytochemical evidenceM Sörhede, C Erlanson-Albertsson, J Mei, et al.Peptides|January 1, 1996
Nitric oxide synthase inhibition attenuates tolerance to morphine but not to [D-Ala2, Glu4] deltorphin II, a delta 2-opioid receptor agonist in miceG M Zhao, H N BhargavaPeptides|January 1, 1996
Modulation of pain perception in man by a vasopressin analogueJ Pohl, H Arnold, A Schulz, et al.Peptides|January 1, 1996
An in vitro investigation of the effects of the ACTH/MSH(4-9) analogue, Org 2766, on guinea pig medial vestibular nucleus neuronsD P Gilchrist, C L Darlington, P F SmithPeptides|January 1, 1996
Studies on the ileum-contracting mechanisms and identification as a complement C3a receptor agonist of oryzatensin, a bioactive peptide derived from rice albuminM Takahashi, S Moriguchi, M Ikeno, et al.Peptides|January 1, 1996
Substance P enhances antigen-evoked mediator release from human nasal mucosaC R Baumgarten, A Witzel, J Kleine-Tebbe, et al.Peptides|January 1, 1996
Interactions between vasopressin and food restriction on stress-induced analgesiaC H Wideman, H M Murphy, S B McCartneyPeptides|January 1, 1996
Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor geneJ J Watters, M W Swank, C W Wilkinson, et al.Peptides|January 1, 1996
A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptidesR V House, P T Thomas, H N BhargavaPageof 982